AUGUST 28, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Jason Cole, CEO and Board Member, Zag Bio, Inc.
In this week’s CEO Q&A, Cole, who lives with type 1 diabetes himself, discusses the science behind Zag’s thymus-targeted platform, what differentiates its approach from other immune-tolerance strategies in development, and his outlook for turning immune tolerance from long-standing scientific aspiration into real therapies for patients. More

Press Releases

  • SpyGlass Pharma: Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space More
  • UCLA Health: Cancer Biosimilars Associated With Lower Costs for Insurers and Patients, Study Finds More

Financial News

  • LSN: Hot Investor Mandates (Updated 8/25) More
  • Tiny Blue Dot Foundation: Awards $9M for 11 New Research Grants Exploring the Science of the Perception Box More
  • UCI: New Data Infrastructure Award to Help Scientific Communities Build Domain-Specific Platforms for Collaborative Data Science and AI More
  • UCLA Health: Dr. Joann Elmore Receives American Cancer Society Research Professor Award to Advance Safe and Equitable AI in Cancer Care More

Media/Misc Coverage

  • Big4Bio CEO Weekly Q&A: Jason Cole, CEO and Board Member, Zag Bio, Inc. More
  • BioPharmGuy News: 2nd Place Finish, Sugar Problems, Ghost Roast, Mummy Issues, Fruit Buds More
  • Biotech & Pharma Updates | August 27, 2026 More
  • Can We REVERSE Cancer Drug Resistance? The New Science of Fighting Cancer | Dr. John Yu, MD - Founder and CEO, Kairos Pharma - Professor and Clinical Chief of Neurosurgery, Cedars-Sinai Podcast
  • More on Amgen, AZ's Tezspire Landing Phase 3 Eosinophilic Esophagitis Win, Turning Up Heat on Dupixent More More More More
  • Multi-Academic Study Finds No Link Between Pesticide Exposure and Autism Traits More
  • Subscribe to LifeSci Startup for Updates on US Startups More

Career Moves

slone
Life Sciences Talent and Consulting Strategist George Quinn Named Partner, Fractional Talent at Slone Partners
Learn More  →
  • Aspen Medical Products: Strengthens Executive Leadership Team With Appointment of Steve Paul as President More
  • Chutes & Ladders—Vivace Revs Up C-Suite Ahead of Pivotal Push More
  • Daiichi Sankyo to Give Commercial Team a Makeover; Novo Nordisk’s GPCR Partner Finds CMO More*
  • OPPORTUNITY: Head of Computational Method Development- Boston More
  • OPPORTUNITY: Chief Operating Officer- Remote More
  • OPPORTUNITY: Computational Scientist - New York More
  • Slone Partners: Fractional Leadership in Biotech and Life Sciences: When it Works and Why More
  • Slone Partners: Places Farhad Ghavami as Chief Executive Officer at SeqCenter More
  • The Lundquist Institute: Meredith Johnston Joins as Chief Development Officer More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: Los Angeles Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

Los Angeles Sponsors

slone
Biocom Logo


Follow us


Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:Los Angeles, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.